Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / UNIT 09/16/2030
-
Total 13F shares
-
11,590,189
-
Share change
-
-34,295,344
-
Total reported value
-
$116,014,261
-
Price per share
-
$10.02
-
Number of holders
-
30
-
Value change
-
-$341,207,848
-
Number of buys
-
10
-
Number of sells
-
59
Institutional Holders of Drugs Made In America Acquisition II Corp. - UNIT 09/16/2030 (DMIIU) as of Q4 2025
As of 31 Dec 2025,
Drugs Made In America Acquisition II Corp. - UNIT 09/16/2030 (DMIIU) was held by
30 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,590,189 shares.
The largest 10 holders included
MMCAP International Inc. SPC, HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, LMR Partners LLP, HEIGHTS CAPITAL MANAGEMENT, INC, Westchester Capital Management, LLC, TIG Advisors, LLC, MILLENNIUM MANAGEMENT LLC, RIVERNORTH CAPITAL MANAGEMENT, LLC, STEADFAST CAPITAL MANAGEMENT LP, and Verition Fund Management LLC.
This page lists
30
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.